Cart
sales@molnova.com
AZ-33
CAS No. 1370290-34-8
AZ-33( AZ-33 | AZ 33 | AZ33 | LDHA Inhibitor 33 )
Catalog No. M17263 CAS No. 1370290-34-8
AZ-33 is an LDHA inhibitor. Binding affinity to 6-His-tagged human LDHA (2 to 322 amino acid residue) expressed in Escherichia coli BL21 (DE3) cells by SPR analysis with an active value of 0.093 μM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 92 | In Stock |
|
| 10MG | 155 | In Stock |
|
| 25MG | 302 | In Stock |
|
| 50MG | 445 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameAZ-33
-
NoteResearch use only, not for human use.
-
Brief DescriptionAZ-33 is an LDHA inhibitor. Binding affinity to 6-His-tagged human LDHA (2 to 322 amino acid residue) expressed in Escherichia coli BL21 (DE3) cells by SPR analysis with an active value of 0.093 μM.
-
DescriptionAZ-33, also known as LDHA Inhibitor 33, is a LDHA Inhibitor. Lactate dehydrogenase A (LDHA), a key enzyme involved in anaerobic glycolysis, is frequently deregulated in human malignancies.
-
In Vitro——
-
In Vivo——
-
SynonymsAZ-33 | AZ 33 | AZ33 | LDHA Inhibitor 33
-
PathwayNeuroscience
-
TargetGluR
-
RecptorLDHA
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1370290-34-8
-
Formula Weight497.56
-
Molecular FormulaC25H27N3O6S
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (200.98 mM)
-
SMILESO=C(O)C(C(=O)O)Cc1ccc(cc1)CCCC(=O)NCCC(=O)Nc1ccc2c(c1)sc(n2)C
-
Chemical Name2-(4-(4-((3-((2-Methylbenzo[d]thiazol-6-yl)amino)-3-oxopropyl)amino)-4-oxobutyl)benzyl)malonic acid
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Ward RA, et al.J Med Chem. 2012 Apr 12;55(7):3285-306.
molnova catalog
related products
-
LY2979165
LY2979165 is an orthosteric agonist of mGluR2 and can be used in studies about serving as an anti-depressant.
-
(S)-MCPG
(S)-MCPG ((+)-MCPG) is a class I/II metabotropic glutamate receptors (mGluRs) antagonist that blocks spatial learning and long-term enhancement of the dentate gyrus in vivo in rats, and can be used to study neurological disorders.
-
LY341495
LY341495 is a potent metabotropic glutamate receptor antagonist that exhibits high activity against a wide range of glutamate receptor subtypes and can be used for the study of neurological disorders.
